Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
ICU
Upturn stock ratingUpturn stock rating

LMF Acquisition Opportunities Inc (ICU)

Upturn stock ratingUpturn stock rating
$0.56
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

07/02/2025: ICU (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

1 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $7

1 Year Target Price $7

Analysts Price Target For last 52 week
$7Target price
Low$0.31
Current$0.56
high$13.85

Analysis of Past Performance

Type Stock
Historic Profit -22.37%
Avg. Invested days 22
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 4.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 07/02/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 7.83M USD
Price to earnings Ratio -
1Y Target Price 7
Price to earnings Ratio -
1Y Target Price 7
Volume (30-day avg) 1
Beta -0.86
52 Weeks Range 0.31 - 13.85
Updated Date 07/2/2025
52 Weeks Range 0.31 - 13.85
Updated Date 07/2/2025
Dividends yield (FY) -
Basic EPS (TTM) -2.34

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -1304.44%

Management Effectiveness

Return on Assets (TTM) -144.37%
Return on Equity (TTM) -

Valuation

Trailing PE -
Forward PE -
Enterprise Value 2897709
Price to Sales(TTM) 18.3
Enterprise Value 2897709
Price to Sales(TTM) 18.3
Enterprise Value to Revenue 6.77
Enterprise Value to EBITDA -8.13
Shares Outstanding 16139100
Shares Floating 9783932
Shares Outstanding 16139100
Shares Floating 9783932
Percent Insiders 1.06
Percent Institutions 5.59

Analyst Ratings

Rating 1
Target Price 7
Buy 1
Strong Buy -
Buy 1
Strong Buy -
Hold -
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

LMF Acquisition Opportunities Inc

stock logo

Company Overview

overview logo History and Background

LMF Acquisition Opportunities Inc. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It was incorporated in 2020.

business area logo Core Business Areas

  • Special Purpose Acquisition Company (SPAC): LMF Acquisition Opportunities Inc. operates as a SPAC, meaning its core activity is identifying and merging with a private operating company. It does not have any core products or services until it completes an acquisition.

leadership logo Leadership and Structure

The company's leadership typically includes a management team experienced in investment and business development. The organizational structure is typical of a SPAC, with a board of directors overseeing the management team's efforts to identify and execute a merger.

Top Products and Market Share

overview logo Key Offerings

  • SPAC IPO: LMF Acquisition Opportunities Inc. raised capital through an Initial Public Offering (IPO) to fund a future acquisition. Market share is not applicable until they merge with an operating company. Competitors are other SPACs looking for target companies.

Market Dynamics

industry overview logo Industry Overview

The SPAC market is cyclical, influenced by overall market conditions and investor sentiment. SPACs are used by companies to go public more quickly than a traditional IPO process.

Positioning

LMF Acquisition Opportunities Inc. is positioned as a SPAC seeking a promising private company to merge with, thus taking it public. Its competitive advantage depends on the management team's experience and network.

Total Addressable Market (TAM)

The TAM for SPACs encompasses the total value of potential target companies. It is very large because SPACs can be formed in any industry. LMF Acquisition Opportunities Inc.u2019s position depends on its ability to find a valuable and suitable target.

Upturn SWOT Analysis

Strengths

  • Capital raised through IPO
  • Experienced management team
  • Flexibility in target selection

Weaknesses

  • Limited operational history
  • Reliance on finding a suitable merger target
  • Dilution potential for existing shareholders

Opportunities

  • Identification of high-growth potential target company
  • Favorable market conditions for mergers and acquisitions
  • Increased investor interest in specific sectors

Threats

  • Inability to find a suitable merger target
  • Increased competition from other SPACs
  • Market downturn impacting merger valuations
  • Regulatory changes affecting SPAC operations

Competitors and Market Share

competitor logo Key Competitors

  • Several Other SPACs
  • Bill Ackman's Pershing Square Tontine Holdings (PSTH)
  • Churchill Capital Corp (CCIV) (defunct)

Competitive Landscape

The competitive landscape is crowded with numerous SPACs seeking merger targets. Competition is high, and success depends on the management team's ability to find a compelling target and execute a successful merger.

Growth Trajectory and Initiatives

Historical Growth: Historical growth is not applicable for a SPAC prior to a merger.

Future Projections: Future growth depends on the success of the merger and the acquired company's growth prospects.

Recent Initiatives: Recent initiatives involve the management team's efforts to identify and evaluate potential merger targets.

Summary

LMF Acquisition Opportunities Inc. is a SPAC looking for a company to take public through a merger. Its success hinges on finding a suitable and valuable target. Potential investors should be aware of the risks associated with SPACs, including dilution and the uncertainty of finding a target. The company needs to find a suitable company to merge with in order to realize any growth.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • SEC Filings
  • Company Website
  • Market Data Providers

Disclaimers:

This analysis is for informational purposes only and should not be considered financial advice. Investment decisions should be based on thorough research and consultation with a qualified financial advisor. Market share data is an estimate based on limited available information.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About LMF Acquisition Opportunities Inc

Exchange NASDAQ
Headquaters Denver, CO, United States
IPO Launch date 2022-10-28
CEO, President & Executive Director Mr. Eric Schlorff
Sector Healthcare
Industry Biotechnology
Full time employees 19
Full time employees 19

SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.